Glucose and metabolic control

Berberine

Meta-analyses support improvements in glycemic and lipid markers, with outcomes influenced by dose, duration, and background therapy.

Evidence Level B

Evidence and Risk Labels

Evidence A/B/C reflects research maturity, and risk levels reflect monitoring needs. These labels support comparison, not diagnosis or treatment decisions.

See full scoring guide

Clinical Snapshot

Effect Size
Moderate fasting glucose, A1C, and triglyceride improvements in selected metabolic cohorts
Safety
Moderate Risk

Can interact with glucose-lowering drugs.

Research Dosing

This reflects common ranges and protocols used in published studies, not personal medical advice.

Typical Daily Dose
900-1500 mg (divided with meals)
Timing
Two to three doses with food
Protocol Duration in Studies
8-24 weeks in metabolic studies

Common research pattern uses ~500 mg two to three times daily with meals.

Best Fit Profiles

  • metabolic reset protocols

Source Links